Bill Taranto
Founder, President & General Partner @ Merck Global Health Innovation Fund
Philadelphia, United States
Bill Taranto is a Series B investor at Merck Global Health Innovation Fund in Philadelphia focused on Software and Health Care. Bill Taranto is the Founder of Merck Global Health Innovation Fund. He attended St. Bonaventure University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Bill Taranto invests in
Stages Bill Taranto invests in
Countries Bill Taranto invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 1 (100%)
- Health Care 1 (100%)
- Personal Health 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Transcarent is a consumer-directed health and care platform for employees of self-insured employers and their families. Using a combination of software, technology, health guides, and data science, the company helps consumers with unbiased information, trusted guidance, and access to high-value care. | $58M / Series B / Jun 10, 2021 |
Co-Investors
Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions.Merck GHI has $500M under management and provides growthcapital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck.With a vision that data will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck's expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.
Merck Global Health Innovation Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bill Taranto
Founder, President & General Partner
|
|||
Bill Taranto
Founder, President & General Partner
|
|||
Dave Stevenson
Managing Director
|
|||
Joe Volpe
Managing Director and Founding Partner
|
|||
David M. Rubin
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bill Taranto invest in?
Bill Taranto invests primarily in Software, Health Care and Personal Health startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bill Taranto?
Public channels for Bill Taranto include LinkedIn and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Bill Taranto last invest?
The most recent investment recorded for Bill Taranto closed in Jun 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
